Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia-Reference-Cited by-同舟云学术

Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia

Published:2020-10-15 Issue:2 Volume:62 Page:308-315
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Gunaratne Madugodaralalage D. S. K.¹^ORCID,Sahakian Alexander J.¹^ORCID,Abeykoon Jithma P.²^ORCID,Ansell Stephen M.²,Gertz Morie A.²^ORCID,Kapoor Prashant²,Paulus Aneel³^ORCID,Ailawadhi Sikander³^ORCID,Reeder Craig B.⁴,Witzig Thomas E.²^ORCID,Habermann Thomas M.²,Novak Anne J.²^ORCID,Lacy Martha Q.²,Kyle Robert A.²,Go Ronald S.²^ORCID,Paludo Jonas²^ORCID

Affiliation:

1. Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

2. Division of Hematology, Mayo Clinic, Rochester, MN, USA

3. Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA

4. Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1832669

Reference25 articles.